The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
William Goodnight, MD, MSCR
Kara B. Markham, MD
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Love Story: Lipid Education for Women’s Heart Health
Pam R. Taub, MD, FACC, FASPC
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kavita R. Kongara, MD, FACG, FACP
Case in Point: The Use of GnRH Antagonists Pre- and/or Post-Surgery and the Potential Consequences of Repeat Surgery
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
James A. Simon, MD, CCD, NCMP, IF, FACOG
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Sawsan As-Sanie, MD
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Linda Bradley, MD
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Pre- and Postoperative Use of GnRH Antagonists
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Kenneth J. Moise Jr., MD
Alloimmune Neutropenia of the Fetus and Newborn
Masja de Haas, MD, PhD
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.